Kimes Busan 2022: ASA therapies protagonists in two stands

10 November 2022 - Trade fairs & Congresses -

After three years of forced stop due to the pandemic and the related restrictions, ASA’s leading therapies - Hilterapia® and MLS® Laser Therapy - are once again protagonists during the Kimes Busan 2022, in South Korea. In addition to providing the opportunity to intercept various professionals in the sector, the event allowed the ASA staff to significantly shorten the distance with local distributors, strengthening collaborative relationships.

“During this edition of Kimes, we had the opportunity to once again meet both the President of Asian Star to confirm our corporate support in the regulatory field for the next season, and the President and the sales team of the sub-dealers respectively for Hilterapia® and MLS® Laser Therapy in South Korea. We also had the opportunity to award a plaque of recognition to Doctor Gwanho Kim, the first to have added a Hiro 3.0, a MiS and an M6 robotic device to his private clinic. A meeting which also allowed us to collect useful feedback on the benefits obtained by using our therapies and to open up new perspectives for possible developments in the medium term”, Giacomo Granozio, ASA Area Manager, explains.

You might also be interested in ...

See all articles

Formacion Laserterapia Universidad Quito
news - 21/09/2022
“After an interruption of 2 years due to the pandemic and travel restrictions, training meetings have resumed, with extremely positive effects especially for the participants who now have the...
Asian Star in ASA HQ
news - 25/07/2022
After two years of exclusively virtual communication with our partners in the Far East, visits to Italy by our international partners and collaborators have resumed.
ASA laser devices at Kimes 2022
news - 17/03/2022
During the “Korea International Medical & Hospital Equipment Show” (Seoul, 10-13 March 2022), co-protagonists at the Asian Star stand (ASA local distributor) were M6 and MiS, which joined HIRO 3....
Blog - 11/09/2024
This research, conducted using the M6 robotic device, is the first of its kind to explore this application, offering new hope to patients suffering from this debilitating side effect of radiotherapy.
Press - 09/09/2024
Benefits, training and initiatives aimed at improving not just the working day are the basis of ASA’s 2024 welfare plan which considers its collaborators’ well-being a trump card.
Press - 05/09/2024
The Colombian newspaper in Barranquilla “Notas de actualidad” has no doubts: the “made in Italy” M8 laser device allows reducing pain and restoring the best quality of life to patients suffering from...